More Aggressive Papillary Thyroid Cancer Found In Obese Patients

More Aggressive Papillary Thyroid Cancer Found In Obese Patients

Editor's Choice
Main Category: Endocrinology
Also Included In: Obesity / Weight Loss / Fitness;  Cancer / Oncology
Article Date: 23 May 2012 - 10:00 PDT

email to a friend   printer friendly   opinions   <!-- rate article
Patient / Public:

Healthcare Prof:

A review published Online First in the Archives of Surgery reveals that physicians see a greater number of obese patients with advanced stage and more aggressive forms of papillary thyroid cancer (PTC).

Thyroid cancer cases in the U.S. are on the increase, with the higher incident rates due to PTC. However, the researchers state that although obesity is a recognized risk factor for various cancers, it remains unclear whether the higher risk of cancer is responsible for the increase or improved detection rates.

They say: "Our study shows that those patients with increasing BMI have a progressively increasing risk in presenting with late-stage PTC. This finding is especially seen in the obese and morbidly obese populations."

Avital Harari, M.D., and her team at LA's UCLA David Geffen School of Medicine reviewed 443 patients' medical records from an academic tertiary care center, with an average age of 48.2 years, who had a total thyroidectomy, i.e. surgery to remove most of the thyroid gland at an initial procedure for PTC or other forms of cancer from January 2004 through March 2011.

The team divided the participants into four categories based on the patients' body mass index (BMI), i.e. normal (18.5-24.9), overweight (25-29.9), obese (30-39.9) and morbidly obese (≥40).

The researchers state: "Greater BMI was associated with more advanced disease stage at presentation. Specifically, the obese and morbidly obese categories presented more as stage III or IV disease," noting that both the obese and morbidly obese groups also had a higher occurrence of PTC tall cell variant, "suggesting that these groups have a higher risk of more aggressive tumor types."

They conclude writing: "Given our findings, we believe that obese patients are at a higher risk of developing aggressive thyroid cancers and thus should be screened for thyroid cancer by sonography, which has been shown to be more sensitive in detecting thyroid cancer than physical examination alone."

Invited Critique: Thyroid Cancer Operations for Obese Patients

Quan-Yang Duh, M.D., from San Francisco's University of California writes in an invited comment:

"Harari and colleagues from UCLA (University of California, Los Angeles) showed us one more reason to be concerned about the current obesity epidemic - obese patients have more advanced thyroid cancer. This parallel increase in the rates of obesity and thyroid cancer is intriguing, but without a much larger population study, we cannot determine whether obesity causes thyroid cancer. However, the authors found that higher body mass index is associated with a later stage of thyroid cancer."

He concludes saying:

"For obese patients with papillary thyroid cancer, the bad news is that the cancer is likely to be more advanced. The good news is that thyroid operation remains safe even in obese patients with advanced disease."

Written By Petra Rattue
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

• Additional
• References
• Citations

"Risk of Advanced Papillary Thyroid Cancer in Obese Patients"
Avital Harari, MD; Brandon Endo, BA; Stacie Nishimoto, BS; Philip H. G. Ituarte, PhD and Michael W. Yeh, MD
Archives of Surgery, May 2012, doi:10.1001/archsurg.2012.713

"Thyroid Cancer Operations for Obese Patients: The Bad News and the Good News"
Quan-Yang Duh, MD
Archives of Surgery , May 2012, doi:10.1001/archsurg.2012.911

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

---

APA

---

Please note: If no author information is provided, the source is cited instead.

---

Add Your Opinion On This Article

'More Aggressive Papillary Thyroid Cancer Found In Obese Patients'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

Privacy Policy | Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.

back to top | home | privacy policy

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.